Rafael Yanez

Filter

2008

Expression and siRNA targeting of PABPN1 as a model for oculopharyngeal muscular dystrophy (OPMd)
Trollet, C., Benstead, J., Graham, I., Yanez, R., Antoniou, M. & Dickson, G., 2008, In: Human Gene Therapy. 19, 4, p. 420 - 420 1 p., 80.
Research output: Contribution to journal › Meeting abstract
Expression and siRNA targeting of PABPN1 as a model for oculopharyngeal muscular dystrophy (OPMD)
Trollet, C., Benstead, J., Graham, I., Yanez, R., Antoniou, M. & Dickson, G., 2008, In: Neuromuscular Disorders. 18, 9-10, p. 799 - 799 1 p.
Research output: Contribution to journal › Meeting abstract
Lentiviral-based gene therapy for oculopharyngeal muscular dystrophy
Bales, O., Yanez, R., Talbot, G., van der Maarel, S. & Antoniou, M., 2008, In: Human Gene Therapy. 19, 4, p. 415 - 415 1 p., 64.
Research output: Contribution to journal › Meeting abstract
Lentiviral-based gene therapy for oculopharyngeal muscular dystrophy
Bales, O., Yanez, R., Talbot, G., Trollet, C., Dickson, G., van der Maarel, S. & Antoniou, M., 2008, In: Human Gene Therapy. 19, 10, p. 1177 - 1177 1 p.
Research output: Contribution to journal › Meeting abstract
2007

Expression and siRNA targeting of PABPN1 as a model for oculopharyngeal muscular dystrophy
Trollet, C., Benstead, J., Foster, H., Graham, I., Yanez-Munoz, R. J., Antoniou, M. & Dickson, G., 2007, In: Human Gene Therapy. 18, 10, p. 986 - 986 1 p.
Research output: Contribution to journal › Meeting abstract

Research output